Delivery Order SPE2DB22D3501-SPE2DB25FTE50

Award Date 10/17/24
Potential Completion Date 11/7/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,138.25, is a firm fixed-price delivery order for RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,360.40 firm fixed-price contract is for the supply of Rhogam Ultra-Filtered Plus syringes, a critical medical product. The award is not set aside and has an ultimate completion date of November 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medications, vaccines, and medical supplies to support various government...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.25 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $2,728.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, to support DLA Troop Support Medical's requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.24 delivery order contract is for the supply of Rhogam Ultra-Filtered Plus syringes, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of October 21, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,325.28 delivery order contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a period of performance through October 4, 2023. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rhogam Ultra-Filtered Plus Syrs. The contract is a delivery order with a firm fixed price of $1,392.60 and an ultimate completion date of May 8, 2023. It is not associated with any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,180.20, is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, and has a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a critical medical product. The $4,720.80 firm fixed price delivery order (SPE2DB20D3101|SPE2DB24FRQT0) has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.80, is a Firm Fixed Price Delivery Order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTE50
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.40, is a delivery order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialty medical product. The contract has a firm-fixed price and an ultimate completion date of November 7, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. The place of performance is Conshohocken, PA.

Generated 1/16/25, 9:11 AM